Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jukema

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 3, 2006
[The availability of only one statin is inadequate]J W Jukema
Current Cardiology Reports|June 22, 2018
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?I Karalis, J W Jukema
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2018
[The (un)predictability of coronary atherosclerosis]T W Elffers, J W Jukema
Annals of the New York Academy of Sciences|June 24, 2000
Tailored therapy to fit individual profiles. Genetics and coronary artery diseaseJ W Jukema, J J Kastelein
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Safety of statins in the new millenniumJ W Jukema, P J Lansberg
Acta Cardiologica|September 9, 1999
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"J W Jukema, M L Simoons
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Torcetrapib increases mortality in patients with a high risk of cardiovascular disorders]P C N Rensen, J W Jukema
American Journal of Physiology. Heart and Circulatory Physiology|July 17, 2001
Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheterP Steendijk, E Staal, J W Jukema, et al.
Pharmacological Research|April 1, 1994
Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapyA J van Boven, J W Jukema, R Paoletti
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 15, 2017
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatmentS C Bergheanu, M C Bodde, J W Jukema
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Nederlands Tijdschrift Voor Geneeskunde|January 3, 2006
[The availability of only one statin is inadequate]J W Jukema
Current Cardiology Reports|June 22, 2018
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?I Karalis, J W Jukema
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2018
[The (un)predictability of coronary atherosclerosis]T W Elffers, J W Jukema
Annals of the New York Academy of Sciences|June 24, 2000
Tailored therapy to fit individual profiles. Genetics and coronary artery diseaseJ W Jukema, J J Kastelein
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Safety of statins in the new millenniumJ W Jukema, P J Lansberg
Acta Cardiologica|September 9, 1999
Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol"J W Jukema, M L Simoons
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Torcetrapib increases mortality in patients with a high risk of cardiovascular disorders]P C N Rensen, J W Jukema
American Journal of Physiology. Heart and Circulatory Physiology|July 17, 2001
Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheterP Steendijk, E Staal, J W Jukema, et al.
Pharmacological Research|April 1, 1994
Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapyA J van Boven, J W Jukema, R Paoletti
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 15, 2017
Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatmentS C Bergheanu, M C Bodde, J W Jukema
Pageof 21